SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
JULY 19, 2004
GenoMed, INC.
-------------
(Exact name of registrant as specified in its charter)
FLORIDA 000-49720 43-1916702
----------------------------- ------------------ ----------------------------
(State or other jurisdiction (Commission file (IRS Employer
of incorporation) number) Identification Number)
9666 Olive Blvd., Suite 310, St. Louis, Missouri 63132
------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
---------------------------------------------------
(314) 652-0500
909 South Taylor Avenue, St. Louis, Missouri 63110
--------------------------------------------------
(Former name or former address if changed since last report)
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
(b) Effective July 19, 2004, the registrant has engaged Rubin, Brown, Gornstein
& Co. LLP ("RBG") of St. Louis, Missouri, to serve as its independent
accountant to audit the registrant's financial statements.
The registrant has not consulted RBG regarding the application of
accounting principles to a specific completed or contemplated transaction
or the type of audit opinion that might be rendered on the registrant's
financial statements, and no written or oral advice was provided by RBG on
any such issue that was a factor considered by registrant in reaching a
decision as to any accounting, auditing or financial reporting issue.
The registrant has not consulted RBG on any matter that was either the
subject of a disagreement or a reportable event with regard to the
registrant's prior auditors.
The registrant has provided a copy of the disclosure in this report to RBG
and offered RBG the opportunity to furnish a letter to the Commission
contemplated by Item 304(a)(2)(D) of Regulation S-K. RBG has advised that
is does not intend to furnish such letter to the Commission.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
GenoMed, Inc.
Dated: July 22, 2004 By: /S/ David Moskowitz
---------------------------
Dr. David Moskowitz
Chairman of the Board and
Chief Executive Officer